Imedex® is an industry leader in providing accredited, independent continuing medical education to health care professionals.

May 17, 2015

Washington, DC
Grand Hyatt
6:15 Pm

The Evolution of Personalized Care: Navigating Mechanisms of Biologic Therapies

Symposium Location

Grand Hyatt Washington
1000 H Street NW
Washington, D.C., USA, 20001
Tel: +1 202 582 1234

The Registration and Information Desk at the Washington, DC Grand Hyatt, Independence Ballroom A will be staffed:
Sunday, May 17, 2015
6:15 pm – 8:30 pm

Registration

Registration is complimentary. Please remember to bring your DDWTM Badge.

Available seating will be based on room capacity. Seating is limited and pre-registration does not guarantee admission, as the room may be overbooked. Early arrival is recommended and seating will be first come first serve until capacity is met.

 

Continuing Medical Education

Imedex®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Imedex®, LLC designates this live educational activity for a maximum 1.5 of AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Who Should Attend

This educational activity is specifically designed for gastroenterologists, hospitalists, internal medicine specialists, and other health-care professionals (physicians-in-training,
nurses, pharmacists, physicians’ assistants, etc.) involved and/or interested in the therapeutic management of patients with IBD.

Objectives

After successful completion of this activity, participants should be better able to:

  • Assess the mechanisms of disease involved in the pathogenesis of IBD
  • Relate the mechanism of action of new and emerging agents to the pathogenesis of IBD
  • For an individual patient, explain the goals of treatment and selected approaches for deliveringIBD care
  • Evaluate the risk and benefits of current and emerging therapies for IBD
  • Plan strategies to overcome common IBD disease management challenges

Faculty

Maria T. Abreu, MD
Miller School of Medicine
University of Miami
Miami, Florida

Stephen B. Hanauer, MD, FACG, AGAF
Northwestern Feinberg School of Medicine
Chicago, Illinois

David T. Rubin, MD, FACG, AGAF
University of Chicago Medicine
Chicago, Illinois

Miguel Reguiero, MD, FACG
University of Pittsburgh
Pittsburgh, Pennsylvania

Scientific Agenda

6:15 pm

Dinner Buffet

6:45 pm

Welcome & Pre-Activity Survey via Audience Response
System (ARS)

6:55 pm

Navigating Mechanisms of Biologic Therapies

7:15 pm

Case-Based Debate: Optimization of Biologic Therapy for the Management of IBD
• Proactive Therapeutic Approach vs ReactiveTherapeutic Approach
• Clinical Treatment Algorithms for IBD
• Step-Up versus Top-Down Management
• Therapeutic Drug Monitoring
• Switching of Biologics
• Risk Benefit Equation
• Shared Decision-Making Process (Optimization of Physician/Patient Interaction)

8:00 pm

Faculty Consensus on Biologic Therapies: What’s the Verdict?
Faculty panel moderated by chair

8:20 pm

Closing Remarks, Recap of Key Messages & Post-Activity
Survey via ARS

8:30 pm

Adjourn

Support

Supported by an educational grant from
Takeda Pharmaceuticals International, Inc. U.S. Region

Array Technology

All slide presentations will be available to view on the electronic device of your choice—laptop, tablet, smart phone, etc., via Array technology*. This is the most convenient way to provide attendees with the most up-to-date information. A book of printed presentations is not available; we encourage you to use your electronic device during the conference for optimal participation.

Organizer

Imedex
11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Twitter: twitter.com/ImedexCME
Facebook: facebook.com/Imedex
Web: www.imedex.com